Intravesical Bacillus Calmette is used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.
Scope of the Report:
In the last several years, Global market of Intravesical Bacillus Calmette developed rapidly, with an average growth rate of 5.33%. In 2018, after a huge decrease and recovery, Global revenue of Intravesical Bacillus Calmette is about 198 M USD.
Since 2017, Sanofi start to shut down its production facility, which caused a large short in the market. On the other hand, other manufacturers like Merck are expanding their capacity to fulfill the market demand.
North America region is the largest consumption of Intravesical Bacillus Calmette, with a sales revenue market share nearly 47.7% in 2018. Europe is the second largest consumer of Intravesical Bacillus Calmette, enjoying sales revenue market share about 35.5% in 2016.
The worldwide market for Intravesical Bacillus Calmette is expected to grow at a CAGR of roughly 8.4% over the next five years, will reach 330 million US$ in 2024, from 220 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Intravesical Bacillus Calmette in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Merck
Japan BCG Laboratory
China National Biotec
Serum Institute of India
GSBPL
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
40mg/Vial
50mg/Vial
60mg/Vial
80mg/Vial
Market Segment by Applications, can be divided into
Hospitals
Clinics
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intravesical Bacillus Calmette product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Intravesical Bacillus Calmette, with price, sales, revenue and global market share of Intravesical Bacillus Calmette in 2017 and 2018.
Chapter 3, the Intravesical Bacillus Calmette competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravesical Bacillus Calmette breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Intravesical Bacillus Calmette market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Intravesical Bacillus Calmette sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Summary:
Get latest Market Research Reports on Intravesical Bacillus Calmette. Industry analysis & Market Report on Intravesical Bacillus Calmette is a syndicated market report, published as Global Intravesical Bacillus Calmette Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Intravesical Bacillus Calmette market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.